WTI Price Forecast: Looks to reclaim $93.00 after defending 38.2% Fibo. support
West Texas Intermediate (WTI) – the benchmark US Crude Oil price – attracts some buyers during the Asian session on Tuesday, snapping a four-day losing streak to sub-$91.00 levels, or a nearly two-week low touched the previous day. The commodity currently trades just below the $93.00 mark, up around 1.40% for the day, as the focus remains on the Middle East crisis.
In the latest developments, Iran's Islamic Revolutionary Guard Corps (IRGC) warned on Monday that it would change the geography of the war if the US escalates the conflict. This keeps the geopolitical risk premium in play and acts as a tailwind for crude oil prices. Meanwhile, improving shipments through the Strait of Hormuz and rising hopes for US-Iran talks at the UN General Assembly might cap the upside for the black liquid.
Crude oil prices hold a bullish bias above the 100-day simple moving average (SMA) at $85.05 and a Fibonacci support band between the 61.8% retracement at $84.27 and the 38.2% retracement at $90.96. That said, momentum indicators have eased, with the Relative Strength Index (RSI) hovering near a neutral 54 and the Moving Average Convergence Divergence (MACD) slipping below its signal line and turning negative on the histogram.
The technical setup, in turn, suggests the latest pullback is more a consolidation within an uptrend than a full-fledged reversal while oil prices stay supported over these structural levels. Meanwhile, weakness below the 38.2% Fibo. level at $90.96 would expose the 50.0% retracement at $87.61 and the deeper 61.8% level at $84.27, all reinforcing the underlying demand zone ahead of the 100-day SMA at $85.05 and lower Fibonacci anchors at $79.51 and $73.44.
On the topside, immediate resistance emerges at the 23.6% retracement at $95.10, with a break above this threshold exposing the cycle high region near $101.79, where buyers could begin to face more pronounced profit-taking pressures.
WTI daily chart
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Trades Around $86K as FOMO Hits Highest Level Since 2024

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.
The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).
